Pds Biotechnology Corp share price logo

Pds Biotechnology Corp Share Price

NASDAQ: PDSB

Small Cap

$0.62

-0.03

(-4.53%)

as on

Pds Biotechnology Corp Stock Performance

as on March 20, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $0.60
    $0.64
    downward going graph

    3.23%

    Downside

    3.23%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.60
    $1.92
    downward going graph

    3.23%

    Downside

    208.87%

    Upside

    downward going graph

Pds Biotechnology Corp share price movements today

Previous Close
$0.65
Open
$0.64
Volume
914.6K
Day's Low - High
$0.60 - $0.64
52 Week Low - High
$0.60 - $1.92

Pds Biotechnology Corp Historical Returns

1 Month Return
-3.53 %
3 Month Return
-29.77 %
1 Year Return
-54.04 %
3 Year Return
-89.87 %
5 Year Return
-88.36 %

Pds Biotechnology Corp Stock Fundamentals & Key Indicators

Check Pds Biotechnology Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$35.5M

EPS (TTM)

-0.8

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-32.2M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-221.81%

Pds Biotechnology Corp vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Pds Biotechnology Corp with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Pds Biotechnology Corp image
Pds Biotechnology Corp
BUY$35.5M-88.36%NA0.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$41.7B115.8%135.118.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$114.7B111.95%29.532.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$32.4BNA114.755.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$78.7B55.68%17.9531.41%

Stock Returns calculator for Pds Biotechnology Corp Stock including INR - Dollar returns

The Pds Biotechnology Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Pds Biotechnology Corp investment value today

Current value as on today

₹53,550

Returns

₹46,450

(-46.45%)

Returns from Pds Biotechnology Corp Stock

₹54,412 (-54.41%)

Dollar Returns*

₹7,962 (+7.96%)

Analyst Recommendation on Pds Biotechnology Corp Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Pds Biotechnology Corp. Average target price of $9

Pds Biotechnology Corp Share Price Target

Get share price movements and forecasts by analysts on Pds Biotechnology Corp.

What analysts predicted

93.11%UPSIDE

Target Price

$9

Current Price

$0.62

Analyzed by

12 Analysts

Target

$9.00

Pds Biotechnology Corp target price $9, a slight upside of 93.11% compared to current price of $0.62. According to 12 analysts rating.

Pds Biotechnology Corp Stock’s Investor Sentiment and Interest

Search interest for Pds Biotechnology Corp Stock has decreased by -4% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-4% versus previous 30 day period

Pds Biotechnology Corp Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
-
-
-
-
-
-
0
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
-
Operating Income
-12
-10
-10
-10
-8
-10
-7
-9
-7
-8
EBITDA
-11
-9
-10
-9
-8
-9
-6
-8
-7
-7
Interest Expense
0
1
1
1
1
1
1
0
2
1
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-12
-10
-10
-10
-9
-10
-7
-9
-9
-9
Income Tax Expense
-1
0
0
0
0
-10,726
870
-1
-
-
Net Income
-11
-10
-10
-10
-8
-10
-7
-8
-9
-9
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
-13463.50%
0.00%
0.00%
0.00%

Pds Biotechnology Corp Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
Operating Income
-39
-51
-43
-15
-14
-21
-41
-43
-36
EBITDA
-39
-51
-3
-7
-14
-21
-40
-40
-33
Interest Expense
1
2
1
0
0
0
1
4
4
Depreciation
-
0
0
0
0
0
0
0
0
Income Before Tax
-40
-53
-3
-7
-14
-21
-42
-44
-38
Income Tax Expense
-1
-2
-2
0
0
-4
-1
-1
0
Net Income
-38
-50
-40
-6
-14
-16
-40
-42
-37
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Pds Biotechnology Corp Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
-10
-10
-10
-8
-10
-7
-8
-9
-9
Operating Cash Flow
-7
-8
-9
-8
-7
-8
-9
-9
-5
Investing Cash Flow
-
-
-
0
0
-28
-
-
-
Financing Cash Flow
0
10
20
0
0
0
7
0
0
Change in Cash
-6
2
10
-8
-7
-8
-1
-8
-5

Pds Biotechnology Corp Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-38
-50
-40
-6
-14
-16
-40
-42
-37
Operating Cash Flow
-32
-40
-33
-18
-13
-12
-25
-33
-35
Investing Cash Flow
0
0
29
29
-
-
-
-
0
Financing Cash Flow
9
22
-20
0
29
48
34
16
20
Change in Cash
-23
-18
-53
12
16
36
8
-17
-14

Global Institutional Holdings in Pds Biotechnology Corp

Funds
Holdings
Armistice Capital, LLC
5.79%
Vanguard Group Inc
3.98%
Blair William & Co
0.51%
Commonwealth Equity Services Inc
0.4%
Renaissance Technologies Corp
0.36%
See all

Pds Biotechnology Corp News & Key Events

  • img

    Today's Timeline - 18 September

    Thu, 06:21 PM

    -

    PDS Biotechnology reports median overall survival of 29.5 months in low PD-L1 expression cohort from VERSATILE-002 trial.

Insights on Pds Biotechnology Corp

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 65.9% return, outperforming this stock by 155.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 22.7% return, outperforming this stock by 76.7%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, PDSB stock has moved down by -89.9%

About Pds Biotechnology Corp

pds biotechnology is a clinical stage biopharmaceutical company developing the next-generation of simpler, safer and more effective immunotherapies for cancer and infectious diseases. pds biotechnology’s proprietary versamune® platform vector is based on synthetic and biodegradable lipids which possess a very specific structure and positive charge. the lipids form nanoparticles which activate and are taken up very efficiently by the immune system. the therapeutic product consists of versamune® formulated with a harmless form of the protein or disease-causing agent associated with the particular disease (the antigen) which our immune systems can recognize and respond to. this antigen could be a unique protein expressed only in the cancer cells and not in healthy cells, or it could be a specific viral protein(s) from an infectious virus for example. pds is in the process of completing its first phase 1 human clinical trial in 2015 for pds0101, and has initiated design and preparati
OrganisationPds Biotechnology Corp
Headquarters303A College Road East, Princeton, NJ, United States, 08540
IndustryBiotechnology
CEODr. Frank K. Bedu-Addo Ph.D.
E-voting on sharesClick here to vote

Key Management of Pds Biotechnology Corp

Name

Title

Dr. Kirk V. Shepard M.D.

Chief Medical Officer

Mr. Lars Robert Boesgaard M.B.A.

Principal Financial & Accounting Officer and CFO

Dr. Gregory L. Conn Ph.D.

Chief Scientific Officer

Mr. Spencer Brown J.D.

Senior VP, General Counsel, Corporate Secretary & Chief Compliance Officer

Ms. Janetta Trochimiuk

Controller

Dr. Frank K. Bedu-Addo Ph.D.

President, CEO & Director

Mr. Stephan Toutain M.B.A., M.S.

Chief Operating Officer

FAQs

What is Pds Biotechnology Corp share price today?

Pds Biotechnology Corp share price today is $0.62 as on at the close of the market. Pds Biotechnology Corp share today touched a day high of $0.64 and a low of $0.6.

What is the 52 week high and 52 week low for Pds Biotechnology Corp share?

Pds Biotechnology Corp share touched a 52 week high of $1.92 on and a 52 week low of $0.6 on . Pds Biotechnology Corp stock price today i.e. is closed at $0.62,which is 67.62% down from its 52 week high and 3.33% up from its 52 week low.

What is Pds Biotechnology Corp's market capitalisation today?

Pds Biotechnology Corp market capitalisation is $0.00T as on .

How to invest in Pds Biotechnology Corp Stock (PDSB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Pds Biotechnology Corp on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Pds Biotechnology Corp Shares that will get you 2.4194 shares as per Pds Biotechnology Corp share price of $0.62 per share as on March 20, 2026 at 1:29 am IST.

What is the minimum amount required to buy Pds Biotechnology Corp Stock (PDSB) from India?

Indian investors can start investing in Pds Biotechnology Corp (PDSB) shares with as little as ₹93.193 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹931.93 in Pds Biotechnology Corp stock (as per the Rupee-Dollar exchange rate as on ). Based on Pds Biotechnology Corp share’s latest price of $0.62 as on March 20, 2026 at 1:29 am IST, you will get 16.1290 shares of Pds Biotechnology Corp. Learn more about fractional shares .

What are the returns that Pds Biotechnology Corp has given to Indian investors in the last 5 years?

Pds Biotechnology Corp stock has given -88.36% share price returns and 27.41% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?